Robert A. Brodsky, Michael R. DeBaun
Title and authors | Publication | Year |
---|---|---|
Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models
Shrestha A, Pillis DM, Felker S, Chi M, Wagner K, Gbotosho OT, Sieling J, Shadid M, Malik P |
Molecular Therapy. Methods & Clinical Development | 2025 |
Genetic Therapies for the First Molecular Disease
Phillip Doerfler, Akshay Sharma, Jerlym Porter, Yan Zheng, Mitchell Weiss |
Journal of Clinical Investigation | 2021 |
Complement in Sickle Cell Disease: Are We Ready for Prime Time?
C Varelas, A Tampaki, I Sakellari, Α Anagnostopoulos, E Gavriilaki, E Vlachaki |
Journal of blood medicine | 2021 |
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
GS Cisneros, SL Thein |
2021 | |
Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither
RJ Jones, MR DeBaun |
Blood | 2021 |
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays
HS Yang, SE Racine-Brzostek, WT Lee, D Hunt, J Yee, Z Chen, J Kubiak, M Cantu, L Hatem, E Zhong, D D'Ambrosio, A Chadburn, L Westblade, M Glesby, M Loda, MM Cushing, Z Zhao |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease
S Desine, BM Hollister, KE Abdallah, A Persaud, SC Hull, VL Bonham |
AJOB Empirical Bioethics | 2020 |